astrazeneca - Search News

China, AstraZeneca

AstraZeneca overhauls management of its China division, FT reports

AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's general manager, the Financial Times reported on Friday, citing two people with direct knowledge of the matter.

The Financial Times · 1d

AstraZeneca overhauls management of its scandal-hit China division

The scandal ensnared the China president Leon Wang, who the company announced in November had been detained, along with several other employees. AstraZeneca shed more than £15bn off its market capitalisation after reports about an investigation by local authorities.

Seeking Alpha on MSN · 1d

AstraZeneca said to have changed management of its China unit

AstraZeneca (NASDAQ:AZN) has changed several key management positions in its China business as the Anglo-Swedish drugmaker looks to boost its sales following the recent detention of its President Leon Wang and several other scandals,

AstraZeneca, breast cancer

Hosted on MSN · 1d

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

ジャパンタイムズ · 19h

AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug

The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.

MarketWatch · 1d

AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.

1don MSN

AstraZeneca's Calquence gains FDA nod for 1L MCL treatment

AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market capitalization of $207.67 billion and ...

AstraZeneca Aims to Restore Trust With New Leadership in China Amid Scandal and Sales Decline

AstraZeneca restructures its China operations following leadership scandals and sales challenges, appointing new executives ...

Harnessing AI and data science to discover life-changing medicines at AstraZeneca

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

News Medical on MSN2d

AstraZeneca's Pioneering Research in Heart Failure and ATTR-CM: An interview with Mina Maker

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be ...

AstraZeneca price target raised to 13,100 GBp from 12,600 GBp at Guggenheim

Guggenheim raised the firm’s price target on AstraZeneca (AZN) to 13,100 GBp from 12,600 GBp and keeps a Buy rating on the shares. The firm is ...

AstraZeneca rises Friday, still underperforms market

AstraZeneca PLC AZN shares inched up 0.87% to £109.38 Friday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 1.35% to 8,505.22.

JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year ahead

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cho0xxI9.js ...

The Power of Personalized Breast Cancer Care

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

China, AstraZeneca

AstraZeneca, breast cancer

Related topics